SIGN UP

Incoming BIO CEO Michelle McMurry-Heath (BIO)

May 14, 2020 09:41 AM EDTUpdated 09:51 AM

BIO gets a new chief lobbyist to face off against the growing ranks of critics in Congress

BIO has selected its next CEO to succeed James Greenwood as one of biotech’s top lobbyists. And she comes with a dream résumé that rings …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE

TRENDING NOW

Patient dies in Neurogene's Rett syndrome study

Lilly's board undergoes more changes; Merck strategy chief joins Roger Perlmutter at Eikon

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Halozyme withdraws Evotec acquisition proposal after biotech is 'unwilling to engage'

From vaccines to psychedelics, five drugmakers on what could change under a Trump administration

sponsored

Are programs with compounded GLP-1s safe for your population?